JAGSONPAL PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 337 INR | +1.86% |
|
+0.06% | -13.33% |
| May. 24 | Jagsonpal Launches Drug for Vasomotor Symptoms; Shares Jump 5% | MT |
| May. 24 | Jagsonpal Launches Memup India's First Bioidentical Hormone Replacement Therapy in A Single Pill | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.
Sector
Pharmaceuticals
Calendar
2024-08-07
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.33% | 105M | |
| +58.87% | 827B | |
| +38.56% | 634B | |
| -7.10% | 350B | |
| +13.66% | 319B | |
| +6.50% | 294B | |
| +12.68% | 240B | |
| +14.48% | 221B | |
| +0.04% | 219B | |
| +7.49% | 167B |
- Stock Market
- Equities
- JAGSNPHARM Stock
- News Jagsonpal Pharmaceuticals Limited
- Jagsonpal Pharmaceuticals' Net Profit Soars in Fiscal Q1
